Rujuta Kanhere, MD in Dallas, TX - Medicare Pathology

Rujuta Kanhere, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Dallas, Texas. She graduated from medical school in 1998 and has 26 years of diverse experience with area of expertise as Pathology. She is a member of the group practice Pathologists Bio-medical Laboratories Pllc and her current practice location is 3600 Gaston Ave, Pathology Department, Dallas, Texas. You can reach out to her office (for appointments etc.) via phone at (214) 820-0111.

Rujuta Kanhere is licensed to practice in Texas (license number N6407) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1386858140.

Contact Information

	Rujuta Kanhere, MD
	3600 Gaston Ave, Pathology Department, Dallas, TX 75246-1800
	(214) 820-0111
	Not Available

Physician's Profile

Full Name	Rujuta Kanhere
Gender	Female
Speciality	Pathology
Experience	26 Years
Location	3600 Gaston Ave, Dallas, Texas
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Rujuta Kanhere graduated from medical school in 1998

NPI Data:

NPI Number: 1386858140
Provider Enumeration Date: 05/10/2007
Last Update Date: 02/04/2015

Medicare PECOS Information:

PECOS PAC ID: 0345464723
Enrollment ID: I20140605001430

Medical Identifiers

Medical identifiers for Rujuta Kanhere such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1386858140	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0101X	Pathology - Anatomic Pathology	4301083957 (Michigan)	Secondary
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	N6407 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Baylor Scott & White Medical Center Plano	Plano, TX	Hospital
Baylor Scott & White The Heart Hospital - Plano	Plano, TX	Hospital
The Heart Hospital Baylor Denton	Denton, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Pathologists Bio-medical Laboratories Pllc	7911961677	46

News Archive

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe hypertension. The product will be available in two vial sizes – 100 mg per 20 mL and 200 mg per 40 mL, multi-dose vials.

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

International Stem Cell Corporation has now enrolled the first U.S.-based donor in its program to establish a bank of clinical-grade human parthenogenetic stem cells (hpSCs) capable of being immune-matched to millions of patients.

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Chronix Biomedical today announced that it will launch a new disease detection and monitoring service for cancer researchers at the upcoming 2010 ASCO Annual Meeting. The "For Investigational Use Only" laboratory-based testing service uses Chronix's breakthrough approach—the Chronix Apoptotic DNA Blood Test—which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Rujuta Kanhere allows following entities to bill medicare on her behalf.

Entity Name	Pathologists Bio-medical Laboratories Pllc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1265477707 PECOS PAC ID: 7911961677 Enrollment ID: O20041112001162

News Archive

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rujuta Kanhere is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Rujuta Kanhere, MD 3600 Gaston Ave, Pathology Dept, Dallas, TX 75246-1800 Ph: (214) 820-2251	Rujuta Kanhere, MD 3600 Gaston Ave, Pathology Department, Dallas, TX 75246-1800 Ph: (214) 820-0111

News Archive

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

Pathology Doctors in Dallas, TX

Dr. Jaime Albert Campbell, M.D., M.S. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave, Baylor University Medical Center, Dept Of Pathology, Dallas, TX 75246 Phone: 214-820-3772
Brianne Flynn, Pathology Medicare: Not Enrolled in Medicare Practice Location: 2355 N Stemmons Fwy, Dallas, TX 75207 Phone: 214-920-5900
Dr. Timothy Joseph Kirtek, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd Stop 7200, Dallas, TX 75390 Phone: 214-648-3433
Keith Allen Wharton Jr., MD PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-1620 Fax: 214-648-4080
Dinesh Rakheja, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-1620 Fax: 214-648-4080
Dr. Emmy L. Kiss, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-590-6494
Thomas Hugh Mcconnell, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3401 Lee Pkwy Apt 304, Dallas, TX 75219 Phone: 214-363-2221 Fax: 214-363-2228

Rujuta Kanhere, MD - Medicare Pathology in Dallas, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Medicare Reassignments

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension

ISCO enrolls first U.S.-based donor to establish clinical-grade human parthenogenetic stem cell bank

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Pathology Doctors in Dallas, TX